Saratoga Investment Corp SAR Q1 2026 Earnings EPS Turns Negative Missing Estimates by a Wide Margin NTLA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Focuses on Pipeline Execution Stratasys SSYS Q1 2026 Earnings EPS Beats Estimates Despite Opaque Revenue Picture AQNB Q1 2026 Earnings FixedtoFloating Note Delivers EPS Beat Amid Stable Utility Operations DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline PNC Financial Services Holds Steady Above 220 as Bulls Eye Key Resistance Fortune Brands Innovations FBIN Rallies 273 as Home Improvement Sentiment Improves NeoVolta NEOV Gains 37 as Energy Storage Demand Fuels Renewed Interest SCYNEXIS SCYX Falls 688 Key Support and Resistance Levels Under Scrutiny CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline